Level D· Scientific groundwork from lab and animal studiesAnimal StudyPubMed

Shoeblackplant extract-loaded carboxymethyl cellulose/collagen scaffolds seeded with adipose-derived stem cells enhance diabetic wound healing via immunomodulation and angiogenic pathways.

Wang X., Yang H., Hu J., Jalili S.

Animal Study on Diabetic Foot, Chronic Wound, Chronic Inflammation, Immune Modulation, published in Tissue Cell (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
Tissue Cell (2026)
Country
Scotland
Reported sample size
—
Source database
PubMed
PMID
41723918
DOI
10.1016/j.tice.2026.103393

Abstract (original English)

Background Diabetic wounds are a chronic condition where the typical cascade of wound healing is compromised due to unresolved inflammation, oxidative stress, and dysfunctional angiogenesis. Bioactive dressings with combined stem cell and plant extract-based formulations can provide a multifactorial therapeutic approach for diabetic wounds. The study was aimed at evaluating the wound healing potential of shoeblackplant extract-loaded carboxymethyl cellulose/collagen (CMCCOL) scaffolds seeded with adipose-derived stem cells in vitro and in vivo. Methods Porous CMCCOL scaffolds loaded with shoeblackplant extract (5 %, 7.5 %, and 10 % v/v) were developed by the freeze-drying method and crosslinked using EDC/NHS. Rat adipose-derived stem cells were seeded on the scaffolds for seven days to fabricate ASCs-seeded CMCCOL scaffolds. The cytocompatibility, MTT assay, bacterial penetration test, anti-inflammatory assay (ELISA), Transwell® migration assay, mechanical tensile strength, biodegradation, and drug release profile was evaluated in vitro. The in vivo wound healing study was performed using a full-thickness wound on diabetic rats and treated with ASC-seeded scaffolds, extract-free scaffolds, commercial dressing (Mepilex® foam), or sterile gauze as a control. On day 14, the wound area reduction and histological analysis (H&E and Masson's Trichrome) were assessed. Wound healing was

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
AnimalsWound HealingCollagenRatsPlant ExtractsNeovascularization, PhysiologicTissue ScaffoldsCarboxymethylcellulose SodiumAdipose TissueStem Cells

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research